Peptide Research Resource

Your Comprehensive Guide to Peptide Research

Explore the latest scientific research on peptides, from healing compounds to cognitive enhancers. Evidence-based articles written for researchers and enthusiasts.

Browse ArticlesPeptide Database
Featured Research

In-Depth Analysis

Comprehensive reviews of the latest peptide research findings

ResearchMetabolic Peptides
9 min

Ecnoglutide: The First 'Biased' GLP-1 Just Got Approved — And the Nausea Numbers Are Striking

On March 6, 2026, China's NMPA approved ecnoglutide for chronic weight management — the world's first cAMP-biased GLP-1 receptor agonist to reach market. The Phase 3 numbers are remarkable not because the weight loss is record-breaking (it isn't), but because the nausea rate at the top dose was 12.7% versus 9.9% on placebo. That's a different shape of side-effect curve than anything we've seen from a GLP-1 before, and it's the first real-world test of biased agonism as a drug-design strategy.

Read article
ResearchMetabolic Peptides
10 min

BRP: Stanford's 12-Amino-Acid 'Natural Ozempic' That Skips the Nausea

A Stanford team used a computational pipeline called Peptide Predictor to comb through 2,683 hypothetical human peptide fragments and pull out a 12-mer they named BRP. In mice and minipigs it cut food intake by up to 50% in an hour and stripped fat without touching lean mass — and it didn't go anywhere near the GLP-1 receptor. Here's what the Nature paper actually shows, what it doesn't, and why it might matter even more than another incretin.

Read article
Research Categories

Explore by Category

Discover peptide research organized by function and application

Healing & Recovery

Peptides studied for tissue repair, wound healing, and regenerative properties. This category covers research on compounds that may support the body's natural healing processes.

Explore

Growth Hormone

GH-releasing peptides and secretagogues research. Explore studies on peptides that interact with growth hormone pathways and their potential applications.

Explore

Cognitive Enhancement

Nootropic and brain-supportive peptides. Research on compounds studied for their potential effects on memory, focus, and neuroprotection.

Explore

Metabolic Peptides

Peptides studied for metabolic function, weight management, and energy regulation. Includes research on compounds affecting metabolism and body composition.

Explore
View all categories
Database

Peptide Compounds

Comprehensive information on research peptides with molecular data

Tirzepatide

Mounjaro, Zepbound, LY3298176

Approved

The first FDA-approved dual GIP/GLP-1 receptor agonist, producing record-breaking weight loss results. Approved for type 2 diabetes (Mounjaro) and chronic weight management (Zepbound).

CategoryMetabolic
View Details

Semaglutide

Ozempic, Wegovy, Rybelsus

Approved

An FDA-approved GLP-1 receptor agonist used for type 2 diabetes and chronic weight management. One of the most effective medications for weight loss, available as once-weekly injection or daily oral tablet.

CategoryMetabolic
View Details

BPC-157

Body Protection Compound-157 (Pentadecapeptide)

Preclinical

A synthetic 15-amino acid peptide derived from human gastric juice protein, extensively studied for tissue healing, gastrointestinal protection, and regenerative properties. One of the most researched peptides in regenerative medicine.

CategoryHealing & Recovery
View Details

TB-500

Thymosin Beta-4

Preclinical

A synthetic peptide derived from the active region of Thymosin Beta-4, widely researched for tissue repair, wound healing, and recovery. TB-500 is one of the most popular healing peptides in research communities.

CategoryHealing & Recovery
View Details

PT-141

Bremelanotide, Vyleesi

Approved

An FDA-approved melanocortin receptor agonist that works in the brain to enhance sexual desire and arousal. Marketed as Vyleesi for hypoactive sexual desire disorder (HSDD) in premenopausal women.

CategorySexual Health
View Details

Ipamorelin

Ipamorelin Acetate

Preclinical

A highly selective growth hormone releasing peptide (GHRP) that stimulates GH release with minimal impact on cortisol and prolactin. Known for its clean side effect profile and synergy with GHRH analogs.

CategoryGrowth Hormone
View Details
View All Peptides
Latest Updates

Recent Articles

Stay up to date with the newest research

Research9 min

Ecnoglutide: The First 'Biased' GLP-1 Just Got Approved — And the Nausea Numbers Are Striking

On March 6, 2026, China's NMPA approved ecnoglutide for chronic weight management — the world's first cAMP-biased GLP-1 receptor agonist to reach market. The Phase 3 numbers are remarkable not because the weight loss is record-breaking (it isn't), but because the nausea rate at the top dose was 12.7% versus 9.9% on placebo. That's a different shape of side-effect curve than anything we've seen from a GLP-1 before, and it's the first real-world test of biased agonism as a drug-design strategy.

Metabolic Peptides
Research10 min

BRP: Stanford's 12-Amino-Acid 'Natural Ozempic' That Skips the Nausea

A Stanford team used a computational pipeline called Peptide Predictor to comb through 2,683 hypothetical human peptide fragments and pull out a 12-mer they named BRP. In mice and minipigs it cut food intake by up to 50% in an hour and stripped fat without touching lean mass — and it didn't go anywhere near the GLP-1 receptor. Here's what the Nature paper actually shows, what it doesn't, and why it might matter even more than another incretin.

Metabolic Peptides
Research14 min

FORZINITY (Elamipretide/SS-31): The First FDA-Approved Mitochondrial Peptide — And What It Signals for the Field

In September 2025, the FDA quietly approved the first mitochondria-targeted peptide therapeutic in history. The drug is FORZINITY — the commercial form of SS-31, a peptide that's been studied in everything from heart failure to age-related macular degeneration to aged-muscle frailty. Here's what the approval actually says, what the trials really showed, and why this is bigger than Barth syndrome.

Anti-Aging & Longevity
Research14 min

Pemvidutide: The GLP-1/Glucagon Peptide That Just Got FDA Breakthrough Status for MASH

In January 2026, the FDA granted Altimmune's pemvidutide Breakthrough Therapy Designation for MASH after Phase 2b data showed 54.7% liver fat reduction, meaningful fibrosis improvement, and a lipid profile unlike anything else in the GLP-1 class. Here's what the data actually shows—and why Phase 3 could reshape fatty liver treatment.

Metabolic Peptides
Continuously Updated

Stay Informed on Peptide Research

Our team continuously reviews and synthesizes the latest scientific literature to bring you accurate, up-to-date information on peptide research.

Explore Database